Identification of double-stranded DNA in the cerebrospinal fluid of patients with acute neuromyelitis optica spectrum disorder
Identification of double-stranded DNA in the cerebrospinal fluid of patients with acute neuromyelitis optica spectrum disorder
复制标题
DOI:
10.1016/j.jocn.2022.12.005
复制
发表时间:
2023-01
影响因子:
2
通讯作者:
Mamoru Yamamoto;T. Okuno;Jin-Lan Piao;Mikito Shimizu;K. Miyamoto;T. Nukui;M. Kinoshita;T. Koda;R. D. Haryuni;H. Mochizuki;T. Sugimoto;Y. Nakatsuji
中科院分区:
文献类型:
--
作者:
Mamoru Yamamoto;T. Okuno;Jin-Lan Piao;Mikito Shimizu;K. Miyamoto;T. Nukui;M. Kinoshita;T. Koda;R. D. Haryuni;H. Mochizuki;T. Sugimoto;Y. Nakatsuji
Neuromyelitis optica spectrum disorder (NMOSD) is an inflammatory disease of the central nervous system (CNS) characterized by severe myelitis and optic neuritis. Double-stranded DNA (dsDNA) is involved in the pathogenesis of various autoimmune diseases, such as systemic lupus erythematosus. However, its role in NMOSD remains unclear. In this study, the concentration of dsDNA in the cerebrospinal fluid (CSF) was quantified in 23 patients with NMOSD and 16 patients with other neurological diseases (ONDs). CSF dsDNA levels in patients with NMOSD (median: 0.03 ng/µL) were significantly higher than those in patients with ONDs (median: 0.01 ng/μl). CSF dsDNA levels showed no significant difference before and after treatment. Elevation of CSF dsDNA levels may suggest its essential role in the augmentation of CNS inflammation in patients with NMOSD.